Capital Impact Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,572	Closed	-$179K	–	136
2021 Q1	$179K	Sell	1,572 -24,010	-94%	-$3.27M	0.06%	106
2020 Q4	$3.54M	Sell	25,582 -25,000	-49%	-$2.97M	0.87%	47
2020 Q3	$4.16M	Buy	50,582 +20,000	+65%	+$1.66M	1.23%	19
2020 Q2	$2.39M	Sell	30,582 -15,340	-33%	-$1.02M	0.8%	57
2020 Q1	$2.04M	Buy	45,922 +1,789	+4%	+$92.9K	0.86%	48
2019 Q4	$1.89M	Hold	44,133	–	–	0.66%	86
2019 Q3	$1.88M	Buy	44,133 +7,968	+22%	+$433K	0.71%	82
2019 Q2	$2.24M	Sell	36,165 -1,693	-4%	-$108K	0.82%	33
2019 Q1	$1.58M	Hold	37,858	–	–	0.7%	65
2018 Q4	$1.58M	Buy	37,858 +9,112	+32%	+$498K	0.68%	68
2018 Q3	$2.29M	Buy	28,746 +1,672	+6%	+$136K	0.79%	43
2018 Q2	$2.06M	Sell	27,074 -4,917	-15%	-$318K	0.76%	44
2018 Q1	$1.63M	Buy	+31,991	New	+$1.61M	0.67%	65